2026 Biologics Analytical R&D & CMC Intern (PhD)

Company Description

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on X, Facebook, Instagram, YouTube, LinkedIn and Tik Tok.

Job Description

Envision spending your summer working with energetic colleagues and inspirational leaders, all while gaining world-class experience in one of the most dynamic organizations in the pharmaceutical industry. This is a reality for AbbVie Interns.  

AbbVie Biologics Analytical Research & Development (BioARD) is a global analytical sciences organization responsible for all CMC analytical activities related to the development of AbbVie's pharmaceutical products.  Our scope includes AbbVie's diverse pipeline of innovative therapeutic biologic medicines and spans from the selection of Discovery candidate molecules through the transition of analytical methods and testing to commercial labs to support product launch.  We are building a world-class team of scientists and leaders who will drive the advancement of industry-leading analytical capabilities and make meaningful contributions to advance AbbVie's pipeline of innovative medicines.  Careers in AbbVie Biologics Analytical R&D provide unique opportunities to work with global and cross-functional teams to drive exceptional science and innovative product development strategies.   

This internship, embracing the biologics characterization group, aims to develop state-of-the-art analytical techniques for higher-order structures (HOS) characterization of complex biologics such as antibody-drug-conjugates (ADCs), using novel chemical labeling techniques. The project focuses on ADC aggregates, where we seek to characterize and localize, at molecular level, the ADC self-association interfaces and capture any allosteric conformational changes upon aggregation, and understand the aggregation formation mechanism, providing potential opportunities to holistically mitigate